Are you taking Cladribine for your MS. Turns out it is pretty decent stuff!
Another example of why we need everyone with MS to sign up to the UK MS Register.
“Over half of MS patients analysed did not relapse or experience disability progression during 60 months of follow-up from the last dose, suggesting that cladribine tablets remain effective in years 3 and 4 after short courses at the beginning of years 1 and 2.”
Browse categories and add by clicking on them
You can remove current categories below by clicking the ‘x’.